ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=MHC class II transactivator {ECO:0000305}; Short=CIITA; EC=2.3.1.- {ECO:0000250|UniProtKB:P33076}; EC=2.7.11.1 {ECO:0000250|UniProtKB:P33076}; | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
1155
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:32551
Panelli MC, et al., Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC. Cancer Immunol Immunother. 1996 Feb;42(2):99-107
J:38736 Sims TN, et al., Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator. Immunogenetics. 1997;45(3):220-2 J:40766 Muhlethaler-Mottet A, et al., Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 1997 May 15;16(10):2851-60 J:297334 Bruchez A, et al., MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science. 2020 Oct 9;370(6513):241-247 J:338142 He K, et al., Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine. Cell. 2023 Jul 6;186(14):3033-3048.e20 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 03/25/2025 MGI 6.24 |
![]() |
|